was calculated by subtracting the LDL, IDL, and HDL cholesterol from the total cholesterol. The total cholesterol content of chylomicrons and extremely large VLDL, very large VLDL and very small VLDL was calculated by subtracting the triglyceride and phospholipid concentrations from the total lipids of each subclass. Lipid composition as a percentage of each available lipid of the total lipid content in each lipoprotein subclass was also calculated.
Liver histology
Liver biopsies were obtained using a Tru-Cut needle (Radiplast AB, Uppsala, Sweden) during elective gastric bypass operations. Overall histological assessment of liver biopsy samples was performed by one pathologist according to the standard criteria ( 23, 24 ) , and histological diagnosis was divided into three categories: 1 ) normal liver without any steatosis, infl ammation, ballooning, or fi brosis; 2 ) simple steatosis (steatosis >5%) without evidence of hepatocellular ballooning, infl ammation, or fibrosis; and 3 ) NASH (supplementary Tables I, II) . When analyzing the effects of the gastric bypass operation, a different histological characterization was used to separate normal from probable and defi nite NASH (supplementary Table III ): steatosis was graded into four categories (<5, 5-33, 33-66, and >66%); lobular infl ammation was graded into four categories (no foci, <2, 2-4, and >4 per 200× fi eld); fi brosis was staged from 1 to 4 and ballooning from 0 to 2. When all four variables were present, the diagnosis was "defi nite steatohepatitis," and when variables one to three were positive, the diagnosis was "probable steatohepatitis." In the absence of lobular infl ammation and steatosis, the diagnosis was "not steatohepatitis". All patients with alcohol consumption >2 doses per day were excluded from the study. Chronic hepatitis B and C (HBV and HCV) were excluded using serology if alanine aminotransferase values were elevated prior to surgery (HCV and HBV infections are rare in Finland ). Hemochromatosis was excluded by histological analysis of liver biopsies, and by normal serum ferritin levels in subjects that had an elevated serum alanine aminotransferase level.
Liver cholesterol content with gas-liquid chromatography
Liver total cholesterol content (per 100 mg liver tissue) was quantifi ed with gas-liquid chromatography (GLC) on a 50 m long capillary column (Ultra 2, Agilent Technologies, Wilmington, DE) using 5 ␣ -cholestane as the internal standard ( 25 ) .
Liver free cholesterol content with NMR spectroscopy
Liver samples (approximately 50 mg) were homogenized in 1.5 ml Eppendorf tubes in NaCl solution (150 l of 150 mM NaCl in D 2 O) by pestle. After homogenization, 300 l of CD 3 OD and 600 l of CDCl 3 were added and samples were mixed vigorously using a vortex mixer and sonicated for 15 min (indirect sonication) in an ice bath. After mixing, the samples were centrifuged (5,000 g , 10 min, 4°C) to separate the organic and water phase. The lower organic phase was recovered and the aqueous layer was extracted again, fi rst with 600 l and then with 300 l CDCl 3 to standardize the yield. The separated organic layers were combined and evaporated to dryness under a gentle fl ow of dried air. Prior to NMR analysis, the extracted lipids were redissolved into 600 l of CDCl 3 containing 0.03% of tetramethylsilane as a reference substance. 1 H NMR spectra of extracted lipids were recorded on a Bruker Avance III HD 600 NMR spectrometer operating at 600.28 MHz and equipped with a Prodigy TCI 5 mm cryogenically cooled probe head. Standard 1D 1 H NMR spectra were recorded with 96,000 data points using 32 transients and applying a standard Bruker zg pulse sequence. The acquisition time was 5 s and the relaxation delay was 15 s. The spectra were measured at 295,000 . increased lipid production in the liver. It has also been suggested that high LDL cholesterol relates to NASH and liver fi brosis ( 11, 12 ) , suggesting that the association of NASH with serum lipids is not only related to increased VLDL synthesis.
We investigated the association between serum lipoprotein subclasses and NASH. Our hypotheses were that dyslipidemia in NASH includes altered lipoprotein subclass lipid profi le, and specifi cally that changes in cholesterol metabolism associate with liver infl ammation and injury. To answer these questions, we investigated serum lipoprotein subclasses using NMR spectroscopy ( 13 ) in 116 obese individuals with detailed liver histology. The main fi nding was that the levels of total lipids and cholesterol in VLDL and LDL subclasses were linked to infl ammation and cell injury in NASH, but not to simple steatosis. These changes were corrected with obesity surgery.
MATERIALS AND METHODS

Subjects
All patients undergoing obesity surgery in Kuopio University Hospital are recruited into our ongoing study investigating metabolic consequences of obesity surgery (Kuopio Obesity Surgery Study) ( 14, 15 ) . The study group included 116 consecutive subjects [age 47.3 ± 8.7 (mean ± SD) years, BMI 45.1 ± 6.1 kg/m 2 , 39 men and 77 women], who were accepted for the Roux-en-Y gastric bypass (RYGB) operation over the years 2005-2010. Fiftynine patients had serum NMR data available also 1 year after the surgery. The study protocol was approved by the Ethics Committee of the Northern Savo Hospital District (54/2005,104/2008, and 27/2010), and it was performed in accordance with the Declaration of Helsinki. Written informed consent was obtained from the subjects.
Laboratory determinations
Diabetes was defi ned by WHO's criteria of diabetes ( 16 ) . Plasma glucose, insulin, serum total cholesterol, HDL cholesterol, and triglyceride levels were analyzed as described before ( 14, 15 ) .
Serum lipoprotein subclass analysis by NMR spectroscopy
Fasting concentrations of lipoprotein subclass particles and their main lipid components were analyzed by proton NMR spectroscopy in native serum samples ( 13, 17, 18 ) . The details of this methodology have been described previously ( 13, 19 ) , and this platform has recently been applied in various large-scale epidemiological and genetic studies (20) (21) (22) . The lipoprotein subclass data available are as follows: chylomicrons and largest VLDL particles (average particle diameter at least 75 nm); fi ve different VLDL subclasses: very large VLDL (average particle diameter of 64.0 nm), large VLDL (53.6 nm), medium VLDL (44.5 nm), small VLDL (36.8 nm), and very small VLDL (31.3 nm); IDL (28.6 nm); three LDL subclasses: large LDL (25.5 nm), medium LDL (23.0 nm), and small LDL (18.7 nm); and four HDL subclasses: very large HDL (14.3 nm), large HDL (12.1 nm), medium HDL (10.9 nm), and small HDL (8.7 nm). The following components of the lipoprotein particles were quantifi ed: phospholipids, triglycerides, and cholesterol. Due to resolution and concentration issues, all of these components are not available for every subclass ( 17, 18, 20 ) . The VLDL cholesterol concentration (version 2.0.1) ( 29 ) . FDR values <0.1 were considered to indicate a statistically signifi cant difference.
RESULTS
Subject characteristics
Seventy-six out of the 116 patients had a clearly defi ned liver phenotype: 32 had normal liver, 19 had simple steatosis, and 25 had NASH ( Table 1 ). Levels of fasting insulin and total and LDL cholesterol ( P = 0.006, P = 0.004, and P = 0.010, Kruskall-Wallis test) differed between study groups. Total and LDL cholesterol were higher in individuals with NASH compared to those with simple steatosis ( P = 0.002 and P = 0.007). The results were essentially the same if individuals using cholesterol-lowering medication (n = 21) were excluded (supplementary Table IV ).
Serum lipids in relation to steatosis, infl ammation, and fi brosis
Next, we investigated to determine whether the association between NASH and serum lipids is related to steatosis, infl ammation, or fi brosis in the liver. To this aim, obese patients were divided into four groups based on severity of steatosis (steatosis grades: <5%, 5-33%, 33-66%, and >66%; supplementary Data processing. The free induction decays (FIDs) with 96,000 data points were zero-fi lled to 256,000 data points and multiplied by an exponential window function with a 0.3 Hz linebroadening. The areas of the known lipid resonances ( 26 ) in the spectra were determined using a constrained total-lineshape fi tting approach to enable quantitative analysis of severely overlapping peaks and to increase the quantifi cation accuracy ( 27 ) . This methodology allowed us to get information on the amounts of several lipid components in the extracted samples, e.g., free cholesterol and total triglycerides. The PERCH NMR software was used for all the lineshape fi tting analyses.
Liver gene expression and genotyping
Quantitative real-time PCR was carried out in the Applied Biosystems 7500 real-time PCR system using KAPA SYBR FAST qPCR Universal Master Mix (Kapa Biosystems, Woburn, MA). Primers are available in supplementary Table III . We genotyped rs738409 SNP of patatin-like phospholipase domain containing 3 ( PNPLA3 ) ( 28 ) (using the TaqMan SNP genotyping assay (Applied Biosystems) according to the manufacturer's protocol.
Statistical analysis
Data are presented as mean ± SD. Differences between the study groups were examined with the 2 test (in categorical variables) and by nonparametric Kruskall-Wallis test (continuous variables). Spearman rank correlation was used for correlation analysis. General linear model analysis was used for studying the independent contributions of variables on liver histology. Analyses were conducted with the SPSS version 19 (IBM SPSS). Multiple testing of several related lipid phenotypes was corrected using false discovery rate (FDR) calculated by the Benjamini-Hochberg method as implicated in the "p adjust method" in R with NASH, but not signifi cantly in those with simple steatosis ( Fig. 1A ).
Next, we investigated the association of total lipoprotein lipid concentration with steatosis, infl ammation, or fi brosis (detailed results in supplementary Tables V-VII). No signifi cant associations were observed between subclass lipid concentration and steatosis (FDR > 0.1, Fig. 1B ), while total lipid concentration in all VLDL, IDL, and LDL subclasses (excluding very small VLDL) was increased by 20-80% in relation to infl ammation ( Fig. 1C ) and grade 1 fi brosis ( Fig. 1D ). Stage 2-4 fi brosis was characterized with lower lipoprotein lipid concentrations than grade 1 ( Fig. 1D ). Furthermore, the total lipid concentration of all VLDL and LDL particles associated with the NAFLD activity score [that measures histological injury in NASH combining information about steatosis, infl ammation, and liver cell injury ( 24 ) ] and with ballooning [a histological marker of liver cell injury in NASH (FDR < 0.1, data not shown)]. The total lipid concentration of HDL subclasses was not altered in relation to steatosis or infl ammation, but stage 1 fi brosis related to higher HDL lipid concentration ( Fig. 1D ).
supplementary Table II , lower part). Steatosis associated with higher fasting insulin levels ( P = 0.002), but not with serum lipids (supplementary Fig. I) . In contrast, lobular infl ammation and stage 1 fi brosis associated with total and LDL cholesterol ( P = 0.0001-0.022; supplementary Fig. IB , C). In addition, individuals with stage 1 fi brosis had higher total triglycerides ( P = 0.008) than individuals without any sign of fi brosis (supplementary Fig. IC ). There was no difference when comparing individuals without fi brosis to those with grades 2-4 fi brosis, suggesting a decline in serum lipids when moving from stage 1 to a more advanced stage of fi brosis.
VLDL and LDL lipid concentration associates with infl ammation, fi brosis, and liver cell injury
The serum lipid and lipoprotein analysis was extended to a more detailed lipoprotein subclass analysis using NMR spectroscopy ( 13, 19 ) ( Fig. 1A ) . Total lipid concentration of VLDL (excluding very small VLDL) and medium and small LDL associated with NASH (FDR < 0.1, Table 2 ). More specifi cally, total lipid concentration of VLDL and LDL subclasses was increased in individuals LDL subclasses). We also demonstrated that the association of lipoprotein cholesterol concentrations with liver infl ammation remained signifi cant when adjusted for fasting insulin ( P = 0.012-0.045).
VLDL cholesterol correlates with liver total and free cholesterol content
To explain the link between lipoprotein cholesterol metabolism and liver disease, we analyzed the association between lipoprotein cholesterol concentrations and liver cholesterol content (n = 52). Liver cholesterol content measured by GLC correlated with lobular infl ammation (r s = 0.393, P = 0.004), as expected, but not signifi cantly with steatosis (r s = 0.258, P = 0.065) and fi brosis (r s = Ϫ 0.186, P = 0.221). Interestingly, liver cholesterol content also correlated with VLDL cholesterol, but not with LDL and HDL cholesterol ( Fig. 2B ). To further study the interaction between liver cholesterol metabolism and NASH, we measured liver free cholesterol content with NMR in the available liver samples (n = 45). First, our observation that liver triglyceride content measured with NMR correlated
We also evaluated whether the lipid composition (as a percentage of individual lipids from total lipids) would alter in NASH. There were no differences in the lipid composition of any lipoprotein subclass in relation to steatosis and infl ammation, and only small changes in relation to fi brosis (supplementary Table VIII ).
VLDL and LDL cholesterol associates with liver infl ammation independent of steatosis and serum triglycerides
The liver cholesterol accumulation has been associated with NASH ( 9, 12, 30 ) , and our traditional lipid analysis supported an association between cholesterol metabolism and NASH (supplementary Fig. I) . The cholesterol concentration of VLDL (except in small VLDL), IDL, and LDL associated with infl ammation and fi brosis (FDR < 0.05; supplementary Fig. II; supplementary Tables V-VII) , but not with steatosis. Importantly, in multivariate analysis the association of VLDL and LDL cholesterol concentration with liver infl ammation was independent of steatosis and serum total triglycerides ( P = 0.024-0.049 for small, medium, and large VLDL and for large and medium infl ammation, or fi brosis (all P > 0.3, data not shown). Thus, the transcriptional upregulation of the cholesterol synthesis genes does not explain the association between VLDL cholesterol and NASH. Interestingly, we found that X-box binding protein 1 ( XBP1 ) splicing in the liver correlated with lobular infl ammation (r s = 0.272, P = 0.014) and ballooning (r s = 0.243, P = 0.029), but not with steatosis (r s = 0.080, P = 0.479). Because XBP1 splicing also associated with cholesterol concentration of small VLDL, IDL, LDL subclasses and medium HDL (r s = 0.220-0.313, P < 0.05), endoplasmic reticulum stress could potentially be a link between cholesterol metabolism and NASH. Although the PNPLA3 genotype has been associated with liver fat ( 15, 31 ) , and also tended to associate with steatosis in our study ( P = 0.080, 2 test), there was no association of the PNPLA3 genotype with serum lipids (all P > 0.2, data not shown).
Obesity surgery normalizes NASH-related lipoprotein abnormalities
To determine whether obesity surgery normalizes NASH-related lipoprotein abnormalities, we analyzed serum NMR results before and after RYGB. The effect of RYGB on total lipid concentration of different lipoprotein subclasses is shown in Fig. 3A (more detailed in supplementary Table XI ). The VLDL and LDL lipid accumulations that were associated with NASH ( Fig. 3B ) decreased signifi cantly after surgery. In contrast, HDL lipid concentration that was not associated with simple steatosis or NASH clearly increased with weight loss. To investigate whether obesity surgery corrects NASH-related dyslipidemia, we divided patients not using cholesterol lowering medication to those without NASH (n = 27) at baseline and to those with possible/defi nite NASH (n = 20, for definition see Materials and Methods) at baseline. The increases in VLDL, IDL, and LDL cholesterol and serum triglycerides in individuals with NASH normalized after surgery to levels comparable with the levels in individuals without NASH (all changes P < 0.05) ( Table 3 ).
DISCUSSION
Our study was set to assess whether lipoprotein subclass metabolism is linked with NAFLD or NASH. High serum VLDL and LDL lipid concentration related to liver infl ammation and fi brosis more than to steatosis ( Fig. 1 ) . More specifi cally, we explored the association of cholesterol metabolism with liver injury in NASH ( 9, 12, 32 ) . Both VLDL and LDL cholesterol concentrations associated with liver infl ammation and fi brosis ( Fig. 2 ) , and VLDL subclass cholesterol concentrations associated also with liver cholesterol content. This association was independent of steatosis and serum triglycerides ( Fig. 2 and multivariate  analysis) suggesting an independent link between VLDL and LDL cholesterol and NASH.
A key fi nding in this study was that high serum VLDL and LDL lipid concentration related to lobular infl ammation in the liver independent of steatosis ( Table 2 , ). Second, free cholesterol content measured with NMR correlated with liver total cholesterol content measured with GLC (r s = 0.419, P = 0.024), but not with steatosis, lobular infl ammation, or fi brosis (supplementary Table IX ). Similarly to total liver cholesterol, liver free cholesterol correlated with all VLDL subclasses (r s = 0.315-0.381, P < 0.005), except with small VLDL (r s = 0.279, P = 0.063), and not with LDL and HDL cholesterol ( Fig. 2C ) .
Because high VLDL cholesterol is linked with increased cholesterol synthesis in the liver, we also explored mRNA expression of genes regulating cholesterol synthesis ( CYP51A1 , DHCR7 , DHCR24 , HMGCR , LSS , SC4MOL ,  SC5D , SREBP1a , SREBP1c , SREBP2 , and TM7SF2 ) and uptake ( LDLR ) in the liver. Although mRNA expression of some genes regulating synthesis tended to correlate with VLDL and LDL cholesterol subclasses (supplementary Table X ), we could not show any association between the expression of cholesterol synthesis genes and steatosis, previous fi ndings suggesting that nonHDL cholesterol (VLDL + LDL) is a biomarker for NASH ( 34 ) .
One potential link between the VLDL and LDL lipid contents and NASH is altered cholesterol metabolism in the liver. Accumulation of liver cholesterol has been suggested to be important in the pathophysiology of NASH ( 9 ) . Cellular free cholesterol, but not free fatty acids or triglycerides, sensitizes to TNF-and Fas-induced steatohepatitis ( 35 ) . The possible explanation is that free cholesterol and multivariate analysis). We also found a link between VLDL and LDL lipid concentration and cell injury in NASH, quantifi ed by the NAFLD score and ballooning ( 24, 33 ) . These data give a more detailed view on lipoprotein subclass metabolism in NASH than earlier fi ndings demonstrating increased VLDL synthesis in steatosis ( 4, 8 ) , leading to the suggestion that high serum VLDL and LDL lipid concentrations are also related to the progression from simple steatosis to NASH. This is in line with is cytotoxic and can activate both Fas-independent and Fas-triggering mitochondrial dysfunction in macrophages ( 36 ) . Thus, it has been proposed that hepatic accumulation of free cholesterol results in cytotoxicity which mediates transition from steatosis to NASH ( 37 ) . It has recently been suggested that the cause for cholesterol accumulation in NASH is increased cholesterol synthesis ( 30 ) . Our gene expression fi ndings in the liver support the suggestion that endoplasmic reticulum stress may be a link between cholesterol metabolism and NASH. We observed that altered splicing of XBP1 related to both NASH and to changes in cholesterol metabolism linked with NASH. Earlier, the IRE ␣ /XBP1 pathway has been suggested to regulate hepatic lipid homeostasis and its dysregulation has been associated with NASH ( 38 ) .
Although both VLDL and LDL cholesterol associated with infl ammation and fi brosis, only VLDL cholesterol correlated signifi cantly with the liver cholesterol content in our study ( Fig. 2B, C ). This suggests that increased synthesis of VLDL particles, rather than decreased release of VLDL ( 39 ) , is the key fi nding in NASH. Although we could not link liver cholesterol accumulation, or increased VLDL cholesterol concentrations, to increased expression of genes regulating cholesterol metabolism, as recently suggested ( 30, 40 ) , our results support the view that changes in lipoprotein subclass metabolism in NASH relate to infl ammation and cell injury in NASH ( 8, 9, 30, (40) (41) (42) .
Importantly, all NASH-related lipoprotein abnormalities were abolished by obesity surgery ( Fig. 3 ) . The decrease in serum LDL cholesterol and total triglycerides, and the increase HDL cholesterol, in response to RYGB has been well-characterized ( 43 ) . In this study we demonstrate that the lipoprotein abnormalities related to NASH can be corrected with RYGB, also at a subclass level. We assume that this is related to the amelioration of NASH. Unfortunately, we had only 11 liver biopsies taken at 1 year follow-up. As expected (44) (45) (46) , they consistently showed improved histology (data not shown).
Although the study population was limited to 116 patients, the detailed histological characterization is more extensive than in most previous studies ( 9, 11, 12, 30 ) . In addition, the analysis of serum concentrations of lipoprotein subclasses, as opposed to using only standard enzymatic methods, was a strength in our study. For example, we could not identify the expected association between serum total triglycerides and NASH ( Table 1 ) , but could clearly demonstrate that triglyceride levels of all VLDL subclasses had association with NASH diagnosis ( Table 2 ). Because of ethical diffi culties to obtain liver biopsies in healthy lean individuals, we only had biopsies from obese individuals. On the other hand, by studying obese individuals, we increased the possibility to fi nd subjects with NASH.
We conclude that VLDL and LDL subclass lipid concentrations are associated with lobular infl ammation and liver cell injury in NASH. More specifi cally, our results support an independent link between VLDL cholesterol, liver cholesterol, and NASH. Finally, we demonstrated that lipoprotein subclass abnormalities in NASH can be reversed with obesity surgery. The authors of "Lipoprotein subclass metabolism in nonalcoholic steatohepatitis" ( J. Lipid Res . 2014. 55: 2676-2684) have informed the Journal that the following errors appeared in the following fi gures in their article: Fig. 1 (p. 2679) The symbols on the graphs in Fig. 1A -D were too small and the symbol colors were unclear. The symbol size is now enlarged and the color of the symbols is now visible.
Fig. 3 (p. 2682)
Two data points on Fig. 3A , L LDL and M LDL, appeared as white squares and should be gray squares. In Fig. 3B , symbols for both NASH baseline and NASH post RYGB were presented as squares. However, NASH post RYGB should be presented as triangles, as correctly stated in the fi gure legend. These errors have been corrected. Symbols on both graphs in Fig. 3A and B have been enlarged for clarity. These corrections do not affect the interpretations of the results or the conclusions of the article. 
